Early cardiac involvement in children carrying the A3243G mtDNA mutation

S B Wortmann1, R J Rodenburg, A P Backx

  • 1Department of Pediatrics, Radboud University Nijmegen Medical Centre, Nijmegen Centre for Mitochondrial Disorders, Nijmegen, The Netherlands.

Insights

The mitochondrial A3243G mutation presents variably in children, often with non-specific symptoms and early cardiac issues. Early cardiac screening is vital, as this mutation may be underdiagnosed and linked to unexplained deaths.

Area of Science:

  • Genetics
  • Pediatrics
  • Cardiology

Background:

  • The mitochondrial A3243G mutation has a variable phenotypic spectrum, especially in children.
  • Pediatric presentation differs from adult MELAS syndrome, often lacking typical encephalopathy or psychomotor regression.

Purpose of the Study:

  • To describe the clinical presentation and cardiac involvement in children with the A3243G mtDNA mutation.
  • To highlight the potential underdiagnosis of this mutation in pediatric populations.

Main Methods:

  • Retrospective analysis of six children with the A3243G mtDNA mutation (heteroplasmy >50% in muscle).
  • Clinical data collection including age at diagnosis, symptoms, and cardiac assessments.

Main Results:

  • Age at diagnosis ranged from 2 weeks to 14.5 years.
  • Non-specific symptoms included muscle weakness, developmental delay, and epilepsy.
  • Five of six children showed presymptomatic cardiac involvement (cardiomyopathy, hypertrophy, rhythm disturbances).
  • Two patients experienced early mortality.

Conclusions:

  • The A3243G mutation may be underdiagnosed, potentially leading to unexplained cardiac deaths.
  • Recommend regular ECGs and echocardiography for all children with the A3243G mtDNA mutation, regardless of cardiac symptoms.
Abstract